These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37529341)

  • 1. Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma.
    Bian Y; Bi G; Shan G; Liang J; Yao G; Sui Q; Hu Z; Zhan C; Chen Z; Wang Q
    Heliyon; 2023 Aug; 9(8):e18132. PubMed ID: 37529341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell N
    Gao Y; Wang H; Chen S; An R; Chu Y; Li G; Wang Y; Xie X; Zhang J
    J Transl Med; 2022 May; 20(1):197. PubMed ID: 35509079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration.
    Nie Y; Yao G; Xu X; Liu Y; Yin K; Lai J; Li Q; Zhou F; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1155009. PubMed ID: 37025404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Cancer Molecular Characterization of m
    Zhu J; Xiao J; Wang M; Hu D
    Front Oncol; 2020; 10():618374. PubMed ID: 33585244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of N6-Methyladenosine (m
    Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y
    Can J Gastroenterol Hepatol; 2022; 2022():3506518. PubMed ID: 36452120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics profiling identifies C1QA/B
    Zheng F; Zhang W; Yang B; Chen M
    Ann Transl Med; 2022 Nov; 10(22):1249. PubMed ID: 36544679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
    Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
    Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
    Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
    Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial energy metabolism correlates with an immunosuppressive tumor microenvironment and poor prognosis in esophageal squamous cell carcinoma.
    Zhang Z; Jin G; Zhao J; Deng S; Chen F; Wuyun G; Zhao L; Li Q
    Comput Struct Biotechnol J; 2023; 21():4118-4133. PubMed ID: 37664173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
    Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
    Front Immunol; 2022; 13():819080. PubMed ID: 35359993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence.
    Zhu Q; Huang X; Yu S; Shou L; Zhang R; Xie H; Liang Z; Sun X; Feng J; Duan T; Zhang M; Xiang Y; Sui X; Jin W; Yu L; Wu Q
    Front Genet; 2022; 13():1043297. PubMed ID: 36324506
    [No Abstract]   [Full Text] [Related]  

  • 16. Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer.
    Wei J; Wu X; Wang S; Liu S; Gao X
    Front Endocrinol (Lausanne); 2023; 14():1138457. PubMed ID: 37091857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
    Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
    Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
    He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
    J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M
    Wang R; Cheng X; Chi D; Liu S; Li Q; Chen B; Xi M
    Discov Oncol; 2023 Jun; 14(1):99. PubMed ID: 37314494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.